-+ 0.00%
-+ 0.00%
-+ 0.00%

ClearPoint Neuro Raises At-the-Market Equity Offering Limit to $150 Million

PUBT·11/18/2026 22:08:14
ClearPoint Neuro Raises At-the-Market Equity Offering Limit to $150 Million
  • ClearPoint Neuro increased its at-the-market common stock offering capacity to $150 million from $50 million on November 18, 2026.
  • The expanded agreement with sales agent Stifel, Nicolaus & Company includes approximately $22.5 million already sold.
  • Shares available for sale under the existing prospectus supplement remain unchanged at approximately $27.5 million.
  • Sales exceeding that remaining amount under the existing registration statement require a new prospectus supplement.
  • Stifel will receive commissions of up to 3% of gross sales proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearPoint Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-467272), on November 18, 2026, and is solely responsible for the information contained therein.